Arylacetamide Deacetylase-Like 1 (AADACL1) Peptide
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Arylacetamide Deacetylase-Like 1 (AADACL1) Peptide is a synthetic peptide.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Arylacetamide Deacetylase-Like 1 (AADACL1) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: C-Terminus: C-RTRNSYIKWLDQN |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 57552, 320024 |
| NCBI Accession | NP_065843.3, NP_001139748.2, NP_001139749.1 |
| Alias | AADACL2 |
| Background | Protein AADACL1 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
anti- AADACL1 antibody
AADACL1(Arylacetamide deacetylase-like 1) is also named as NCEH1, KIAA1363 and belongs to the 'GDXG' lipolytic enzyme family. The transmembrane enzyme, AADACL1, controls the production of the monoalkylglycerol ether(MAGE) class of NELs in cancer cells and acts as a 2-acetyl MAGE hydrolase and is likely the principal source for this activity in tumor cells(PMID:21513884). The full length protein has three glycosylation sites and can be N-glycosylated(PMID:19159218). It has 3 isoforms produced by alternative splicing.
Ver Producto
Arylacetamide Deacetylase-Like 1 (AADACL1) Antibody
Arylacetamide Deacetylase-Like 1 Antibody is a Rabbit Polyclonal antibody against Arylacetamide Deacetylase-Like 1.
Ver ProductoNeutral cholesterol ester hydrolase 1 (NCEH1) Antibody
NCEH1 Antibody is a Rabbit Polyclonal against NCEH1.
Ver Producto